Clinical trials are underway to see if an anti-malaria drug that treats lupus and rheumatoid arthritis can help treat coronavirus.
Patients fear this could lead to a shortage for those who now rely on the medicine.
Demand for COVID-19 cure could impact some lupus patients
Credit: NewsChannel 5 Nashville
Duration: 01:55s
0 shares
1 views
WERE ALREADY AVAILABLE TO FIRSTRESPONDERS AND HEALTH CAREWORKERS.